冥想后
发表于 2025-3-27 00:36:52
http://reply.papertrans.cn/20/1906/190570/190570_31.png
Ataxia
发表于 2025-3-27 03:14:18
The Global Landscape on the Access to Cancer Medicines for Breast Cancer: The ONCOLLEGE Experience,nd formulate solutions for all patients. In this chapter, we discuss drivers of access to innovation for patients with breast cancer, based on a case study of access to HER2-diagnositcs and therapeutics yielding a global landscape analysis, based on the efforts and expertise of the global collaborative group “ONCOLLEGE”.
具体
发表于 2025-3-27 09:18:31
Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detecives of women found to carry a high-risk mutation (i.e., “cascade testing”) as it is in these individuals for whom such actionable information can result in cancers (and/or cancer deaths) being averted. Moreover, even in the absence of clinical cancer genetics services, as is the case for the immedi
高调
发表于 2025-3-27 11:03:29
http://reply.papertrans.cn/20/1906/190570/190570_34.png
果仁
发表于 2025-3-27 16:06:29
http://reply.papertrans.cn/20/1906/190570/190570_35.png
破裂
发表于 2025-3-27 19:53:06
http://reply.papertrans.cn/20/1906/190570/190570_36.png
赏心悦目
发表于 2025-3-28 00:19:56
Mechanisms of Endocrine Resistance in Hormone Receptor-Positive Breast Cancer, anti-estrogen drugs and result in constitutive activation of the receptor, even in the absence of estrogens. Epigenetic changes, such as DNA methylation and histone modifications, can also contribute to ET resistance by altering the expression of genes that are involved in estrogen signaling. Under
皮萨
发表于 2025-3-28 03:07:37
http://reply.papertrans.cn/20/1906/190570/190570_38.png
监禁
发表于 2025-3-28 09:42:29
http://reply.papertrans.cn/20/1906/190570/190570_39.png
acrimony
发表于 2025-3-28 11:26:38
http://reply.papertrans.cn/20/1906/190570/190570_40.png